These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7870665)

  • 1. First-pass effect of cis-3,4-dichloro-N-methyl-N-(2-(1-pyrrolidinyl)- cyclohexyl)-benzamide (U-54494) in rats--a model with multiple cannulas for investigation of gastrointestinal and hepatic metabolism.
    Zhong WZ; Williams MG; Cook KJ; VandeGiessen TL; Jones BW; Rousch KE
    Pharm Res; 1994 Nov; 11(11):1524-9. PubMed ID: 7870665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the anticonvulsant U-54494A on cortical neuron excitability: comparison to the kappa agonist U-50488H.
    Ochoa MC; Vogelsang GD; Lum JT; VonVoigtlander PF; Piercey MF
    Life Sci; 1992; 50(17):1225-33. PubMed ID: 1349150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of the individual enantiomers of cis-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl]-benzamide monohydrochloride (U-54494A) in the dog.
    Zhong WZ; Williams MG; Schuette MR; Vandegiessen TL; Jones BW
    Enantiomer; 1996; 1(2):89-96. PubMed ID: 9676281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro depressant effects of U-54494A, an anticonvulsant related to kappa opioids, in the hippocampus.
    Proietti ML; Scotti de Carolis A; Frank C; Zeng YC; Sagratella S
    Neuropharmacology; 1991 Jun; 30(6):637-42. PubMed ID: 1656303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two metabolites of anticonvulsant U-54494A: their anticonvulsant activity and interaction with sodium channel.
    Zhu Y; Im WB; Lewis RA; Althaus JS; Cazers AR; Nielsen JW; Palmer JR; Von Voigtlander PF
    Brain Res; 1993 Mar; 606(1):50-5. PubMed ID: 8384924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticonvulsant and related effects of U-54494A in various seizure tests.
    Fischer W; Bodewei R; VonVoigtlander PF; Müller M
    J Pharmacol Exp Ther; 1993 Oct; 267(1):163-70. PubMed ID: 8229743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. U-54494A: a unique anticonvulsant related to kappa opioid agonists.
    VonVoigtlander PF; Hall ED; Ochoa MC; Lewis RA; Triezenberg HJ
    J Pharmacol Exp Ther; 1987 Nov; 243(2):542-7. PubMed ID: 2824750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-independent pharmacokinetics of metformin in rats: Hepatic and gastrointestinal first-pass effects.
    Choi YH; Kim SG; Lee MG
    J Pharm Sci; 2006 Nov; 95(11):2543-52. PubMed ID: 16937336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Block of voltage-gated potassium currents by anticonvulsant U-54494A in mouse neuroblastoma cells.
    Zhu Y; Im HK; Im WB
    J Pharmacol Exp Ther; 1992 Oct; 263(1):207-13. PubMed ID: 1403785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal first-pass effect of YJA-20379-8, a new reversible proton pump inhibitor, in rats.
    Kim J; Kim EJ; Han KS; Chang MS; Lee MG
    J Pharm Pharmacol; 1999 Sep; 51(9):1031-6. PubMed ID: 10528986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of ipriflavone, an isoflavone derivative, after intravenous and oral administration to rats hepatic and intestinal first-pass effects.
    Kim SH; Lee MG
    Life Sci; 2002 Feb; 70(11):1299-315. PubMed ID: 11883708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of DA-8159, a new erectogenic, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects.
    Shim HJ; Kim YC; Park KJ; Kim DS; Kwon JW; Kim WB; Lee MG
    J Pharm Sci; 2003 Nov; 92(11):2185-95. PubMed ID: 14603504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal and hepatic first-pass metabolism of aspirin in rats.
    Iwamoto K; Takei M; Watanabe J
    J Pharm Pharmacol; 1982 Mar; 34(3):176-80. PubMed ID: 6121895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Block of sodium channel current by anticonvulsant U-54494A in mouse neuroblastoma cells.
    Zhu Y; Im WB
    J Pharmacol Exp Ther; 1992 Jan; 260(1):110-6. PubMed ID: 1309869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of age on gastrointestinal and hepatic first-pass effects of levodopa in rats.
    Iwamoto K; Watanabe J; Yamada M; Atsumi F; Matsushita T
    J Pharm Pharmacol; 1987 Jun; 39(6):421-5. PubMed ID: 2886598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver and gastrointestinal first-pass effects of azosemide in rats.
    Kim J; Kim SH; Lee MG
    J Pharm Pharmacol; 1997 Sep; 49(9):878-83. PubMed ID: 9306255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic and intestinal first-pass effects of oltipraz in rats.
    Bae SK; Kim JW; Kim YH; Kim YG; Kim SG; Lee MG
    Biopharm Drug Dispos; 2005 May; 26(4):129-34. PubMed ID: 15744718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The kappa opioid-related anticonvulsants U-50488H and U-54494A attenuate N-methyl-D-aspartate induced brain injury in the neonatal rat.
    Hudson CJ; Von Voigtlander PF; Althaus JS; Scherch HM; Means ED
    Brain Res; 1991 Nov; 564(2):261-7. PubMed ID: 1725768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonism of kainic acid lesions in the mouse hippocampus by U-54494A and U-50488H.
    Camacho Ochoa M; Jackson TA; Aaron CS; Lahti RA; Strain GM; Von Voigtlander PF
    Life Sci; 1992; 51(14):1135-43. PubMed ID: 1325589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of oral, peripheral intravenous, and intraportal glucose on hepatic glucose uptake and insulin and glucagon extraction in conscious dogs.
    Ishida T; Chap Z; Chou J; Lewis R; Hartley C; Entman M; Field JB
    J Clin Invest; 1983 Aug; 72(2):590-601. PubMed ID: 6348094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.